Health Notices




NEW ZEALAND GAZETTE, No. 131

26 SEPTEMBER 2013

Provisional Consent to the Distribution of a New Medicine

Pursuant to section 23(1) of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto:

Schedule

Product: Daunorubicin

Active Ingredient: Daunorubicin hydrochloride 21.4mg/10mL equivalent to Daunorubicin 2mg/mL

Dosage Form: Solution for injection

New Zealand Sponsor: Pfizer New Zealand Limited

Manufacturer: Pfizer (Perth) Pty Limited, Perth, Australia

Note: This consent is valid for two years from the date of publication of this notice.

Dated this 19th day of September 2013.

DR DON MACKIE, Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).

go6156

New Zealand Public Health and Disability Act 2000

The Funded Family Care Notice 2013

Name

  1. This is the Funded Family Care Notice 2013.

Authority

  1. This Notice is a legal document issued by the Minister of Health, for the Crown.

  2. This Notice is issued under section 88 of the New Zealand Public Health and Disability Act 2000.

  3. This Notice is part of a family care policy made under Part 4A of that Act. This Notice must be read with that policy.

Parties to the Notice

  1. This Notice is between the Ministry of Health and the disabled person; it also recognises the responsibilities of the family carer and Ministry’s agents.

Acceptance of terms and conditions

  1. The disabled person accepts these terms and conditions when they accept their first payment for the funding.

  2. These terms and conditions can only be amended by the Minister of Health; and at any time.

Effective date and application

  1. This Notice is effective from 1 October 2013, and applies to funded family care from that date.

Overview

  1. This Notice sets out the funding arrangements of the Government’s family care policy that are required to enable the Ministry to pay a disabled person to receive funded family care, and for that disabled person to use that funding to employ a family carer.

  2. Funded family care is described in the Funded Family Care Operational Policy. Essentially it is:

    (a) for personal care and household management services;

    (b) provided by a family carer to a disabled person who meets the eligibility criteria;

    (c) provided to the disabled person up to a maximum of 40 hours a week; and

    (d) paid at the rate of the minimum wage for adults.

  3. Funded family care is provided through a 5–way partnering relationship among the disabled person, family carer, Ministry, and Ministry’s agents (NASC and Host), requiring:

    (a) the Ministry to pay the disabled person for funded family care;

    (b) the disabled person to use the funding to employ a family carer to provide the funded family care;

    (c) the disabled person and the family carer to prepare an individual service arrangement;

    (d) the family carer to provide the funded family care according to the arrangements reflected in the individual service arrangement; and

    (e) the Ministry’s agent to:

     NASC
    
     (i) assess and co-ordinate the disability support services needs of the disabled person;
    
     (ii) monitor the delivery of the funded family care;
    
     (iii) assist with the management of problems; and
    
     (iv) audit the payment and service arrangements.
    
     Host
    
     (v) assist with the set-up of the funded family care;
    
     (vi) help the disabled person and family carer prepare the individual service arrangement; and
    
     (vii) assist with initial and on-going advice on the employment relationship between the disabled person and the family carer.


Next Page →



Online Sources for this page:

Gazette.govt.nz PDF NZ Gazette 2013, No 131





✨ LLM interpretation of page content

🏥 Provisional Consent to the Distribution of a New Medicine

🏥 Health & Social Welfare
19 September 2013
Medicines Act, Provisional Consent, Daunorubicin, Pfizer
  • DR DON MACKIE, Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health

🏥 Funded Family Care Notice 2013

🏥 Health & Social Welfare
Public Health and Disability Act, Funded Family Care, Disability Support Services